Cabaletta Bio, Inc. Common Stock (CABA) is a publicly traded Healthcare sector company. As of October 6, 2026, CABA trades at $2.12 with a market cap of $339.09M and a P/E ratio of -0.95. CABA moved +4.25% today. Year to date, CABA is -5.02%; over the trailing twelve months it is -14.75%. Its 52-week range spans $0.99 to $4.23. Analyst consensus is strong buy with an average price target of $14.67. Rallies surfaces CABA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CABA shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $2.12 |
| Market Cap | $339.09M |
| P/E Ratio | -0.95 |
| EPS | $-2.10 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.23 |
| 52-Week Low | $0.99 |
| Volume | 4.92M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-167.86M |
| Gross Margin | 0.00% |
8 analysts cover CABA: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.67.